Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vladimir Brusic & Nikolai Petrovsky. (2005) Immunoinformatics and its relevance to understanding human immune disease. Expert Review of Clinical Immunology 1:1, pages 145-157.
Read now
Read now
John F Barrett. (2005) MRSA – what is it, and how do we deal with the problem?. Expert Opinion on Therapeutic Targets 9:2, pages 253-265.
Read now
Read now
John F Barrett. (2004) MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance. Expert Opinion on Therapeutic Targets 8:6, pages 515-519.
Read now
Read now
Articles from other publishers (37)
Ratnamala S. Bendre, Rahul D. Patil, Pramod N. Patil, Harun M. Patel & Rakesh S. Sancheti. (2022) Synthesis and characterization of new Schiff-bases as Methicillin resistant Staphylococcus aureus (MRSA) inhibitors. Journal of Molecular Structure 1252, pages 132152.
Crossref
Crossref
Fortunato Palma Esposito, Colin J. Ingham, Raquel Hurtado-Ortiz, Chantal Bizet, Deniz Tasdemir & Donatella de Pascale. (2018) Isolation by Miniaturized Culture Chip of an Antarctic bacterium Aequorivita sp. with antimicrobial and anthelmintic activity. Biotechnology Reports 20, pages e00281.
Crossref
Crossref
Vineet K. Singh, Sirisha Sirobhushanam, Robert P. Ring, Saumya Singh, Craig Gatto & Brian J. Wilkinson. (2018) Roles of pyruvate dehydrogenase and branched-chain α-keto acid dehydrogenase in branched-chain membrane fatty acid levels and associated functions in Staphylococcus aureus. Journal of Medical Microbiology 67:4, pages 570-578.
Crossref
Crossref
Johanna Marcela Vanegas Múnera, Ana María Ocampo Ríos, Daniela Montoya Urrego & Judy Natalia Jiménez Quiceno. (2017) In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid. The Brazilian Journal of Infectious Diseases 21:5, pages 493-499.
Crossref
Crossref
Seung-Gyun Woo, So-Yeon Lee, So-Min Lee, Kyoung-Hee Lim, Eun-Ju Ha & Yong-Bin Eom. (2016) Activity of novel inhibitors of Staphylococcus aureus biofilms. Folia Microbiologica 62:2, pages 157-167.
Crossref
Crossref
Saiful Azmi Johari, Mastura Mohtar, Sharifah Aminah Syed Mohammad, Rohana Sahdan, Zurina Shaameri, Ahmad Sazali Hamzah & Mohd Fazli Mohammat. (2015)
In Vitro
Inhibitory and Cytotoxic Activity of MFM 501, a Novel Codonopsinine Derivative, against Methicillin-Resistant
Staphylococcus aureus
Clinical Isolates
. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Maya A. Farha, Chris P. Verschoor, Dawn Bowdish & Eric D. Brown. (2013) Collapsing the Proton Motive Force to Identify Synergistic Combinations against Staphylococcus aureus. Chemistry & Biology 20:9, pages 1168-1178.
Crossref
Crossref
Ana M. Ocampo, Lina M. Echeverri & J. Natalia Jiménez. (2013) Determinación de la susceptibilidad a la vancomicina en cepas de Staphylococcus aureus meticilino-resistente (SaRm) aisladas en un hospital de tercer nivel de complejidad de medellín mediante varias pruebas de sensibilidad antimicrobiana. Hechos Microbiológicos 3:1, pages 41-48.
Crossref
Crossref
Thiago Silva de Almeida, João Batista T. Rocha, Fabíola Fernandes G. Rodrigues, Adriana Rolim Campos & José Galberto M. da Costa. (2013) Chemical composition, antibacterial and antibiotic modulatory effect of Croton campestris essential oils. Industrial Crops and Products 44, pages 630-633.
Crossref
Crossref
Peter Angehrn, Erwin Goetschi, Hans Gmuender, Paul Hebeisen, Michael Hennig, Bernd Kuhn, Thomas Luebbers, Peter Reindl, Fabienne Ricklin & Anne Schmitt-Hoffmann. (2011) A New DNA Gyrase Inhibitor Subclass of the Cyclothialidine Family Based on a Bicyclic Dilactam−Lactone Scaffold. Synthesis and Antibacterial Properties. Journal of Medicinal Chemistry 54:7, pages 2207-2224.
Crossref
Crossref
Sanjai Saxena & Charu Gomber. (2010) Surmounting antimicrobial resistance in the Millennium Superbug: Staphylococcus aureus. Open Medicine 5:1, pages 12-29.
Crossref
Crossref
P. Nobmann, P. Bourke, J. Dunne & G. Henehan. (2009)
In vitro
antimicrobial activity and mechanism of action of novel carbohydrate fatty acid derivatives against
Staphylococcus aureus
and MRSA
. Journal of Applied Microbiology.
Crossref
Crossref
Smitha Rao, Katrijn Bockstael, Sangeeta Nath, Yves Engelborghs, Jozef Anné & Nick Geukens. (2009)
Enzymatic investigation of the
Staphylococcus aureus
type I signal peptidase SpsB - implications for the search for novel antibiotics
. FEBS Journal 276:12, pages 3222-3234.
Crossref
Crossref
Dieter Haebich & Franz von Nussbaum. (2009) Lost in Transcription-Inhibition of RNA Polymerase. Angewandte Chemie International Edition 48:19, pages 3397-3400.
Crossref
Crossref
Dieter Haebich & Franz von Nussbaum. (2009) Sand im Getriebe - Inhibition der RNA-Polymerase. Angewandte Chemie 121:19, pages 3447-3451.
Crossref
Crossref
Vandana Kalia, Rajni Miglani, Kedar P. Purnapatre, Tarun Mathur, Smita Singhal, Seema Khan, Sreedhara R. Voleti, Dilip J. Upadhyay, Kulvinder Singh Saini, Ashok Rattan & V. Samuel Raj. (2009) Mode of Action of Ranbezolid against Staphylococci and Structural Modeling Studies of Its Interaction with Ribosomes. Antimicrobial Agents and Chemotherapy 53:4, pages 1427-1433.
Crossref
Crossref
B.I. Eisenstein. (2008) Treatment challenges in the management of complicated skin and soft-tissue infections. Clinical Microbiology and Infection 14, pages 17-25.
Crossref
Crossref
Colin J. Dunsmore, Keith Miller, Katy L. Blake, Simon G. Patching, Peter J.F. Henderson, James A. Garnett, William J. Stubbings, Simon E.V. Phillips, Deborah J. Palestrant, Joseph De Los Angeles, Jennifer A. Leeds, Ian Chopra & Colin W.G. Fishwick. (2008) 2-Aminotetralones: Novel inhibitors of MurA and MurZ. Bioorganic & Medicinal Chemistry Letters 18:5, pages 1730-1734.
Crossref
Crossref
Ian Chopra, Christopher Schofield, Martin Everett, Alex O'Neill, Keith Miller, Mark Wilcox, Jean-Marie Frère, Mike Dawson, Lloyd Czaplewski, Uros Urleb & Patrice Courvalin. (2008) Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. The Lancet Infectious Diseases 8:2, pages 133-139.
Crossref
Crossref
Lorenzo Drago, Elena De Vecchi, Lucia Nicola & Maria Rita Gismondo. (2007) In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureussevere respiratory infections. BMC Infectious Diseases 7:1.
Crossref
Crossref
Vineet K. Singh, Sugunya Utaida, Letitia S. Jackson, R. K. Jayaswal, Brian J. Wilkinson & Neal R. Chamberlain. (2007) Role for dnaK locus in tolerance of multiple stresses in Staphylococcus aureus. Microbiology 153:9, pages 3162-3173.
Crossref
Crossref
A. Parnés & K. M. Lagan. (2007) Larval therapy in wound management: a review. International Journal of Clinical Practice 61:3, pages 488-493.
Crossref
Crossref
J.F. Barrett. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
731
748
.
Liangsu Wang & John F. Barrett. 2007. Methicillin-Resistant Staphylococcus aureus (MRSA) Protocols. Methicillin-Resistant Staphylococcus aureus (MRSA) Protocols
209
225
.
Phaik-Eng Sum. (2006) Case studies in current drug development: ‘glycylcyclines’. Current Opinion in Chemical Biology 10:4, pages 374-379.
Crossref
Crossref
W. T. M. Jansen, M. M. Beitsma, C. J. Koeman, W. J. B. van Wamel, J. Verhoef & A. C. Fluit. (2006)
Novel Mobile Variants of Staphylococcal Cassette Chromosome
mec
in
Staphylococcus aureus
. Antimicrobial Agents and Chemotherapy 50:6, pages 2072-2078.
Crossref
Crossref
M. A. Jabra-Rizk, T. F. Meiller, C. E. James & M. E. Shirtliff. (2006)
Effect of Farnesol on
Staphylococcus aureus
Biofilm Formation and Antimicrobial Susceptibility
. Antimicrobial Agents and Chemotherapy 50:4, pages 1463-1469.
Crossref
Crossref
Vladimir P. Zharov, Kelly E. Mercer, Elena N. Galitovskaya & Mark S. Smeltzer. (2006) Photothermal Nanotherapeutics and Nanodiagnostics for Selective Killing of Bacteria Targeted with Gold Nanoparticles. Biophysical Journal 90:2, pages 619-627.
Crossref
Crossref
Schuyler Antane, Craig E. Caufield, William Hu, David Keeney, Pornpen Labthavikul, Koi Morris, Shaughnessy M. Naughton, Peter J. Petersen, Beth A. Rasmussen, Guy Singh & Youjun Yang. (2006) Pulvinones as bacterial cell wall biosynthesis inhibitors. Bioorganic & Medicinal Chemistry Letters 16:1, pages 176-180.
Crossref
Crossref
Jodi M Thomson & Robert A Bonomo. (2005) The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!. Current Opinion in Microbiology 8:5, pages 518-524.
Crossref
Crossref
John F Barrett. (2005) Can biotech deliver new antibiotics?. Current Opinion in Microbiology 8:5, pages 498-503.
Crossref
Crossref
Kim Lewis & Alexander M. Klibanov. (2005) Surpassing nature: rational design of sterile-surface materials. Trends in Biotechnology 23:7, pages 343-348.
Crossref
Crossref
Dirk M. Elston. (2005) New and emerging infectious diseases. Journal of the American Academy of Dermatology 52:6, pages 1062-1068.
Crossref
Crossref
John F Barrett. (2005) Adjunct antimicrobial therapy – prospects for the future. Therapy 2:1, pages 67-76.
Crossref
Crossref
John F Barrett. (2005) Adjunct antimicrobial therapy - prospects for the future. Therapy 2:1, pages 67-76.
Crossref
Crossref
Alexander John O'Neill, Keith Miller, Brunello Oliva & Ian Chopra. (2004) Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 54:6, pages 1127-1129.
Crossref
Crossref
Peter Angehrn, Stefan Buchmann, Christoph Funk, Erwin Goetschi, Hans Gmuender, Paul Hebeisen, Dirk Kostrewa, Helmut Link, Thomas Luebbers, Raffaello Masciadri, Joergen Nielsen, Peter Reindl, Fabienne Ricklin, Anne Schmitt-Hoffmann & Frank-Peter Theil. (2004) New Antibacterial Agents Derived from the DNA Gyrase Inhibitor Cyclothialidine. Journal of Medicinal Chemistry 47:6, pages 1487-1513.
Crossref
Crossref